JP2013509378A5 - - Google Patents

Download PDF

Info

Publication number
JP2013509378A5
JP2013509378A5 JP2012535827A JP2012535827A JP2013509378A5 JP 2013509378 A5 JP2013509378 A5 JP 2013509378A5 JP 2012535827 A JP2012535827 A JP 2012535827A JP 2012535827 A JP2012535827 A JP 2012535827A JP 2013509378 A5 JP2013509378 A5 JP 2013509378A5
Authority
JP
Japan
Prior art keywords
compound
sodium
calcium
diagnostic composition
ion concentration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012535827A
Other languages
English (en)
Japanese (ja)
Other versions
JP5335147B2 (ja
JP2013509378A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2010/066351 external-priority patent/WO2011051387A1/en
Publication of JP2013509378A publication Critical patent/JP2013509378A/ja
Publication of JP2013509378A5 publication Critical patent/JP2013509378A5/ja
Application granted granted Critical
Publication of JP5335147B2 publication Critical patent/JP5335147B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012535827A 2009-10-29 2010-10-28 優れた安全性プロファイルを有する血漿陽イオンを含む診断用組成物 Expired - Fee Related JP5335147B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP09174413 2009-10-29
EP09174413.6 2009-10-29
PCT/EP2010/066351 WO2011051387A1 (en) 2009-10-29 2010-10-28 Diagnostic composition comprising plasma cations having superior safety profile

Publications (3)

Publication Number Publication Date
JP2013509378A JP2013509378A (ja) 2013-03-14
JP2013509378A5 true JP2013509378A5 (enExample) 2013-05-09
JP5335147B2 JP5335147B2 (ja) 2013-11-06

Family

ID=43503035

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012535827A Expired - Fee Related JP5335147B2 (ja) 2009-10-29 2010-10-28 優れた安全性プロファイルを有する血漿陽イオンを含む診断用組成物

Country Status (21)

Country Link
US (1) US8815210B2 (enExample)
EP (1) EP2493511B1 (enExample)
JP (1) JP5335147B2 (enExample)
KR (1) KR101545045B1 (enExample)
CN (1) CN102596257B (enExample)
AU (1) AU2010311478B2 (enExample)
BR (1) BR112012009859B1 (enExample)
CA (1) CA2773685C (enExample)
CO (1) CO6531477A2 (enExample)
DK (1) DK2493511T3 (enExample)
ES (1) ES2435299T3 (enExample)
HR (1) HRP20130991T1 (enExample)
IL (1) IL218456A (enExample)
IN (1) IN2012DN02126A (enExample)
MX (1) MX2012005021A (enExample)
NZ (1) NZ598540A (enExample)
PL (1) PL2493511T3 (enExample)
PT (1) PT2493511E (enExample)
RU (1) RU2544113C2 (enExample)
WO (1) WO2011051387A1 (enExample)
ZA (1) ZA201203505B (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO333914B1 (no) * 2011-12-21 2013-10-21 Ge Healthcare As Stabilisering av diagnostisk røntgensammensetning
NZ626988A (en) 2012-01-11 2015-10-30 Ge Healthcare As X-ray imaging contrast media with low iodine concentration and x-ray imaging process
SG11201507964TA (en) * 2013-03-27 2015-10-29 Ge Healthcare As Method and reagent for preparing a diagnostic composition
US10575744B2 (en) 2017-02-24 2020-03-03 Medtronic Cryocath Lp Pericardial balloon mapping
CN109876157B (zh) * 2019-02-27 2020-12-15 浙江大学 离子特异性滤膜/介孔硅的复合材料、纳米传感器及其产品和应用
CN120114620B (zh) * 2025-03-18 2025-12-09 海南普利制药股份有限公司 一种碘帕醇注射液及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3364536D1 (en) * 1982-11-08 1986-08-21 Nyegaard & Co As X-ray contrast agents
GB8906130D0 (en) * 1989-03-17 1989-05-04 Nycomed As Compositions
GB9020091D0 (en) * 1990-09-14 1990-10-24 Nycomed As Contrast media
DE4344464A1 (de) * 1993-12-22 1995-06-29 Schering Ag Kaskadenpolymere mit Iodaromaten
GB9419203D0 (en) * 1994-09-23 1994-11-09 Nycomed Innovation Ab Contrast media
US8066970B2 (en) * 2006-05-11 2011-11-29 Ge Healthcare As Contrast agents
HRP20140649T1 (hr) * 2007-07-12 2014-09-26 Ge Healthcare As, Intellectual Property Dept. Kontrastna sredstva

Similar Documents

Publication Publication Date Title
JP2013509378A5 (enExample)
MX343721B (es) Composiciones, metodos y sistemas para la sintesis y el uso de agentes trazadores.
JP2011518833A5 (enExample)
TR201904041T4 (tr) Protein agregasyonu ile bağlantılı hastalıklarda ve/veya nörodejeneratif hastalıklarda rol oynayan proteinlerin agregasyonunu inhibe etmeye yönelik ilaçlar.
MD20130095A2 (ro) Compuşi condensaţi de benzoxazepinone ca modulatori ai canalelor ionice
JP2011207901A5 (enExample)
WO2014026079A3 (en) Compositions, methods, and systems for the synthesis and use of imaging agents
JP2015512943A5 (enExample)
JP2014533655A5 (enExample)
EA200602077A1 (ru) Активируемые частицы, их получение и применение
JP2008115170A5 (enExample)
MX352546B (es) Compuesto para la union de glicoproteina iib/iiia especifica a plaquetas y su uso para la formacion de imagenes de un trombo.
RU2013156999A (ru) Композиции для ухода за полостью рта, содержащие фитиновую кислоту
EA201300053A1 (ru) Фосфатсвязывающий препарат для удобного приема
NZ708529A (en) Salt and solvates of a tetrahydroisoquinoline derivative
JP2017511377A5 (enExample)
JP2013508315A5 (enExample)
BR112012021579A2 (pt) traçador de tomografia por emissão de pósitron, composto precursor, método para preparar o composto precursor, cassete, composição radiofarmacêutica, método de formação de imagem por tomografia por emissão de pósitron, e, método para diagnose de uma condição.
MX2011010295A (es) Reactivos de radiomarcado y metodos.
MX336387B (es) Composiciones antitranspirantes anhidras.
EA201290245A1 (ru) Радиоактивно меченные pde10 лиганды
HRP20130991T1 (hr) Dijagnostiäśki sastav nadmoä†nog sigurnosnog profila koji obuhvaä†a katione plazme
JP2018502150A5 (enExample)
JP2014534173A5 (enExample)
EA201300479A1 (ru) Соединения для применения в визуализации, диагностике и/или лечении заболеваний центральной нервной системы